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The aggregation of the microtubule-associated tau pro-
tein and formation of “neurofibrillary tangles” is one of
the hallmarks of Alzheimer disease. The mechanisms un-
derlying the structural transition of innocuous, natively
unfolded tau to neurotoxic forms and the detailed mech-
anisms of binding to microtubules are largely unknown.
Here we report the high-resolution characterization of
the repeat domain of soluble tau using multidimensional
NMR spectroscopy. NMR secondary chemical shifts de-
tect residual -structure for 8–10 residues at the begin-
ning of repeats R2–R4. These regions correspond to se-
quence motifs known to form the core of the cross--
structure of tau-paired helical filaments. Chemical shift
perturbation studies show that polyanions, which pro-
mote paired helical filament aggregation, as well as mi-
crotubules interact with tau through positive charges
near the ends of the repeats and through the -forming
motifs at the beginning of repeats 2 and 3. The high de-
gree of similarity between the binding of polyanions and
microtubules supports the hypothesis that stable micro-
tubules prevent paired helical filament formation by
blocking the tau-polyanion interaction sites, which are
crucial for paired helical filament formation.
Alzheimer disease is characterized by abnormal protein de-
posits in the brain, such as amyloid plaques or neurofibrillary
tangles, formed by fibrous assemblies of the A peptide (1) or of
the microtubule (MT)1-associated tau protein (2). These aggre-
gates are thought to be toxic to neurons, either by causing some
toxic signaling defect or by obstructing the cell interior. There-
fore, one of the top priorities in Alzheimer research is to un-
derstand the reasons for the pathological aggregation and to
find methods to prevent it. Although the structural principles
governing A aggregation are known in some detail, little is
known for the tau protein.
Tau is a microtubule-associated protein that regulates MT
stability, neurite outgrowth, and other MT-dependent func-
tions. The three or four repeats in the C-terminal half of the
protein and the flanking proline-rich basic domains are known
to be involved in MT binding (3). The affinity is regulated by
phosphorylation particularly at KXGS-motifs in the repeats (4).
Interestingly the same phosphorylation sites have an inhibi-
tory influence on aggregation (5). Unbound tau can assemble
into Alzheimer-like paired helical filaments (PHFs) whose po-
lymerization can be enhanced by oxidation of SH groups and by
polyanions (e.g. heparin, poly-Glu (6)). On the other hand, tau
has a hydrophilic character, is highly soluble, and belongs to
the class of natively unfolded proteins with no apparent or-
dered secondary structure detectable by far-UV CD or Fourier-
transform infrared spectroscopy (7, 8). Therefore, it is unclear
why tau should aggregate in a specific manner and what struc-
tural principles could be responsible for this.
Tau can aggregate as an intact protein, 352–441 residues in
length (depending on isoform), so that all six tau isoforms are
found in Alzheimer PHFs (9). The isoforms differ by two inserts
near the N-terminal end and the presence of either four or
three imperfect repeat sequences in the C-terminal half of the
protein (see Fig. 1). The region comprising the repeat se-
quences forms the core of PHFs (10) and also promotes PHF
assembly in vitro (11, 12). For PHF aggregation two hexapep-
tides at the beginning of the second and third repeats (275VQI-
INK280 and 306VQIVYK311) are crucial. These are able to ini-
tiate the aggregation of tau into bona fide paired helical
filaments with cross--structure and thereby represent mini-
mal tau-tau interaction motifs (13, 14).
Because tau is a highly flexible protein, it has resisted all
attempts at crystallization for a high-resolution x-ray struc-
ture. X-ray analyses exist only in the form of solution scattering
(confirming the unfolded nature of the protein, (7)) and fiber
diffraction (confirming the cross--structure of PHFs, (13)). We
have now applied NMR spectroscopy as an alternative ap-
proach to structural studies. Here we report the high-resolu-
tion characterization of the repeat domain of tau, in which
either all four repeats are present (K18) or repeat two has been
deleted (K19), corresponding to the adult and fetal tau isoforms
htau40 and htau23 (see Fig. 1). Our findings show that the
repeat domain of soluble tau contains regions of residual
-structure that have the potential to serve as seeds for aggre-
gation of tau into PHFs, and we identify residues involved in
the interaction with MTs and with polyanions that promote
PHF-aggregation.
EXPERIMENTAL PROCEDURES
Expression of Recombinant Tau Constructs and Isotope Labeling—
Human tau constructs were expressed in the vector pNG2 (a derivative
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Supplemental Material can be found at: 
of pET-3a, Merck-Novagen, Darmstadt) in Escherichia coli strain
BL21(DE3) as described (Gustke et al. (3)) (see Fig. 1). K18 comprises
all four repeats of the largest tau isoform (residues Gln244-Glu372 plus
initial Met243), K19 is similar but lacks the second repeat, correspond-
ing to fetal tau (residues Met243  Gln244-Lys274, Val337-Glu372, without
R2  Val275-Ser305). The expressed proteins were purified from bacte-
rial extracts by making use of the heat stability of the protein and by
FPLC SP-Sepharose chromatography (Amersham Biosciences). To label
the tau proteins with 15N and 13C stable isotopes, the E. coli culture
expressing K18 protein was grown in a M9 minimal medium with
15NH4Cl (1 g liter
1) and 13C glucose (4 g liter1) (Campro Scientific),
and the E. coli culture expressing K19 protein was grown on rich
growth medium based on chemolithoautotrophic bacteria labeled with
13C and 15N isotopes (Silantes). Protein samples uniformly enriched in
15N were prepared by growing E. coli bacteria in minimal medium
containing 1 g liter1 of 15NH4Cl.
The cell pellets were resuspended in boiling extraction buffer (50 mM
MES, 500 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 5 mM dithiothreitol, pH
6.8) complemented with a protease inhibitor mixture. The cells were
disrupted with a French pressure cell and subsequently boiled for 20
min. The soluble extract was isolated by centrifugation, the superna-
tant was dialyzed against two changes of cation exchange chromatog-
raphy buffer A (20 mM MES, 50 mM NaCl, 1 mM EGTA, 1 mM MgCl2, 2
mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, pH 6.8) and
loaded on an FPLC SP-Sepharose column. The proteins were eluted by
a linear gradient of cation exchange chromatography buffer B (20 mM
MES, 1 M NaCl, 1 mM EGTA, 1 mM MgCl2, 2 mM dithiothreitol, 0.1 mM
phenylmethylsulfonyl fluoride, pH 6.8). NMR samples contained 0.9–
1.5 mM 15N- or 15N/13C-labeled protein in 95% H2O, 5% D2O, 50 mM
phosphate buffer, pH 6.8, with 1 mM dithiothreitol.
Preparation of MTs—Porcine brain tubulin was purified as described
(15) and incubated at concentrations higher than 200 M in MT assem-
bly buffer (100 mM Pipes, pH 6.9, 1 mM EDTA, 1 mM MgSO4, 1 mM
dithiothreitol) in the presence of 1 mM GTP at 37 °C for 5 min. After
addition of 100 M Paclitaxel (Sigma-Aldrich) the polymerization was
performed for 20 min at 37 °C.
Electron Microscopy—Proteins were diluted to a concentration of
0.1 mg/ml, placed on 600-mesh carbon-coated copper grids for 1 min,
washed with two drops of H2O, and negatively stained with 2% uranyl
acetate for 45 s. The specimen were examined in a Philipps 12M
electron microscope at 100 kV.
NMR Spectroscopy—NMR spectra were acquired at 5 °C on Bruker
DRX 800, Avance 600, and DRX 600 NMR spectrometers. Aggregation
did not occur under these low temperature conditions. NMR data were
processed and analyzed using nmrPipe (16) and Sparky 3. Three-di-
mensional triple-resonance experiments were collected to obtain se-
quence-specific assignments for the backbone of K18 and K19 (supple-
mental Table S1). Secondary shift values were calculated as the
differences between the measured C/C chemical shifts and the empir-
ical random coil value for the appropriate amino acid type at pH 3.0
(17). Random coil values for histidines, glutamates, and aspartates
were taken from Wishart et al. (18), as the chemical shifts of these
residues are particularly sensitive to pH, and the pH in the studies by
Wishart et al. (18) (pH 5.0) is more similar to the one used here (pH 6.9).
To estimate the -sheet propensity in contiguous segments of tau, the
observed C secondary shifts were normalized by the empirically deter-
mined secondary shift expected for that residue type in a fully -sheet
conformation (18), summed, and normalized by the number of residues
in the segment.
Tau-polyanion titrations were carried out with uniformly 15N-labeled
protein containing 0.2 mM (heparin titration) and 0.3 mM (poly-Glu titra-
tion) K18, and 0.12 mM (heparin titration) and 0.14 mM (poly-Glu titra-
tion) K19 at pH 6.8. Heparin (average molecular weight 3000, 5.8
disaccharide subunits, charge/subunit 2.5, 0.31 z/Å) and poly-Glu (av-
erage molecular weight 10,000, 7–8 Glu residues, 7–8 negative net
charge, in extended conformation 0.33 z/Å) were from Sigma. Complex
formation was monitored by recording two-dimensional 1H-15N HSQC
spectra for increasing polyanion concentrations (in mM): 0.03, 0.06, 0.15,
0.3, 0.58, 1.37, and 2.53 (K18 with heparin), 0.008, 0.015, 0.03, 0.072,
0.142, 0.28, 0.68, 1.3, 2.4, and 4.3 (K18 with poly-Glu), 0.008, 0.015, 0.03,
0.07, 0.14, 0.28, 0.67, and 1.3 (K19 with heparin), and 0.015, 0.03, 0.074,
0.146, 0.29, 0.70, 1.35, and 2.49 (K19 with poly-Glu). For tau-MT titra-
tions NMR samples contained 0.13 and 0.14 mM uniformly 15N-labeled
K18 and K19, respectively. Complex formation was monitored at 5 and
20 °C for MT concentrations (-tubulin dimers) of 26.5, 79.5, and 159.0
M in the K18 titrations, and 2.8, 5.4, 20.0, 35.0, and 84.3 M in the K19
titration. Normalized weighted average chemical shift differences for am-
ide 1H and 15N chemical shifts upon polyanion/MT binding were calcu-
lated using av(NH)  [(H
2  (N/5)2)/2]1/2, where H and N are the
differences between the free and bound chemical shifts.
RESULTS
Backbone Resonance Assignment of K18 and K19—NMR
resonances in 1H-15N HSQC spectra of the tau repeat domain
constructs K18 and K19, uniformly labeled with 15N, were
recorded at 5 °C and pH 6.9. The resonances were sharp and
showed only a limited dispersion of chemical shifts, reflecting a
high degree of backbone mobility and unfolded nature, in
agreement with CD and FTIR measurements (7, 13). To enable
a study of the structure and dynamics of tau with atomic
resolution, the assignment of the NMR resonances was re-
quired. Assignment of globular proteins with a molecular mass
FIG. 1. A, tau isoforms and tau-derived constructs. The bars show the tau isoform htau40 and the constructs K18 and K19. The isoform htau40
is the largest one in the human central nervous system (441 residues). According to the isoform the C-terminal half contains three or four
pseudorepeats (31 residues each, R1–R4, gray shade), which are involved in MT binding and form the core of PHFs. The constructs K18 and K19
represent the repeat domains of htau40, comprising four repeats or three repeats, respectively. The positions of the hexapeptides 275VQIINK280 and
306VQIVYK311 in R2 and R3 are underlined. Domain boundaries are labeled by the residue numbers. B, amino acid sequence of the repeat domain
of tau. The sequence shows the four-repeat construct K18, repeat R2 (275–305) is absent in K19, corresponding to the alternative splicing of exon
10. The overall character of the protein is hydrophilic and basic. Each repeat terminates with a characteristic PGGG motif. Identical amino acids
in all repeats are marked by a dashed line; similar amino acids are indicated by a double dot.
Conformations and Interactions of Tau 24979
 at M
ax Planck Inst.Biophysikalische Chem
ie,O
tto Hahn Bibl,Pf.2841,37018 G
oettingen on M









below 15 kDa is straightforward today using multidimensional
NMR techniques. Backbone assignment of K18 (130 residues)
and K19 (99 residues) was complicated, however, by the limited
dispersion of NMR resonances because of the absence of well
defined secondary and tertiary structure elements. In addition,
only five amino acid types make up more than 50% of the
primary sequence, and these amino acids are arranged in se-
quence motifs that occur repetitively, further increasing NMR
signal overlap. Therefore, an unambiguous assignment was not
possible just relying on the conventional three-dimensional
spectra HNCO, HN(CA)CO, HNCACB and CBCA(CO)NH (19).
A high-resolution (HA)CANNH (20) together with three-di-
mensional HNN and HN(C)N experiments were required (21).
With these NMR spectra the backbone resonance assignment
of K18 and K19 could be achieved in an iterative fashion based
on automatic assignment using the program MARS (22) and
manual assignment mainly relying on the HNN experiment.
The sequence motif PGGG, which is located characteristically
at the C-terminal end of each of the four repeats, caused the
biggest problems. Because of severe chemical shift overlap, it
was only possible to assign Gly273, Gly304, and Gly335. The
resonances of the remaining glycines within these motifs could
be identified in the spectra but not unambiguously assigned to
one of the repeats. Otherwise, all 1H, 15N, 13C, 13C, and 13C
chemical shifts were assigned in both K18 and K19.
Soluble Tau Contains Residual -Structure—NMR chemical
shifts, in particular of C and C atoms, are very sensitive
probes of secondary structure both in globular and unfolded
proteins (Ref. 23 and Wishart et al. (18)). These shifts show
small but distinct deviations from random coil values for both
K18 and K19 (Fig. 2). In the case of K18, continuous stretches
(containing more than six amino acids) of negative C second-
ary chemical shifts were found for residues Lys274-Leu284,
Ser305-Leu315, and Gln336-Asp345 (numbering according to the
longest isoform htau40), indicative of nascent -structure (Fig.
2A). These stretches lie at the beginning of repeats R2, R3, and
R4, downstream from PGGG motifs and encompass the
hexapeptide motifs VQIINK and VQIVYK known to be impor-
tant for the abnormal aggregation of tau into PHFs (8). In case
of C, negative secondary chemical shifts were detected for a
similar range of residues, Gly273-Leu282, Gly304-Asp314, and
Gly335-Asp345 (supplemental Fig. S1). It is notable that the
preponderance of negative secondary chemical shifts persists
even at the beginning of the less homologous repeats R1 (res-
idues Ala246-Leu253) and R5 (Asn368-Ile371). In the case of R1
this is likely not because of a propensity to form -structure but
rather because of the occurrence of three prolines (Pro247,
Pro249, Pro251). Indeed, the C secondary chemical shifts alter-
nated in this region consistent with the fact that C atoms of
residues preceding prolines show unusual chemical shifts due
to the absence of an amide proton in the proline. In the case of
R5 the results must be viewed with caution because of the
presence of only three residues of R5 (not counting the C-
terminal residue). A remarkably similar pattern is observed for
K19 even though repeat R2 (exon 10) is absent (Fig. 2C),
suggesting that the repeats represent independent structural
units. A quantitative analysis of the averaged C and C sec-
ondary chemical shifts (Fig. 2B) indicates that -structure-like
conformations are populated 16, 24, and 13% of the time for
residues Lys274-Asp283, Ser305-Asp314, and Gln336-Asp345, re-
spectively. Besides the regions in the beginning of each repeat,
residues 295KDNIK299 and 357LDNIT361 in repeats R2 and R4
show a stretch of negative C/C secondary shifts, indicating a
-structure propensity. Note that no -structure propensity is
present in the corresponding region of repeat 3 (325LGNIH329),
possibly because of the presence of a glycine (Fig. 2B).
The regions of high propensity for the -structure are limited
upstream by PGGG motifs, where the three glycines show
positive C and C secondary chemical shifts in all four repeats.
This indicates either a helical propensity or a turn, in agree-
ment with the fact that GGK and GGS sequences (present in
R1 or R2) are the most common motifs in classic -turns.
Alternatively, the PGGG motif is also common in type II
-turns. The downstream ends of the regions of high -struc-
ture propensity are most prominently identified by positive
C/C secondary chemical shifts of the 10th and/or 11th residue
in repeat 2–4 (Ser285, Ser316, Phe346) (Fig. 2B). Taking further
into account that sequence dyads such as 285SN286 and
316SK317 (the motifs following high -propensity regions in R2
and R3) are common in type I -turns, the C and C secondary
chemical shifts suggest a -turn at the C-terminal end of the
regions of high -structure propensity.
In conclusion, 8–10 residues at the beginning of repeats 2–4
show a residual -structure sandwiched between regions with
a high turn propensity. The most pronounced -structure pro-
pensity is present at the N terminus of the third repeat,
whereas in the second and fourth repeat it is approximately a
factor of 1.5–2 lower. These -conformations in K18 and K19
are presumably in rapid exchange with random like structures.
The C secondary chemical pattern observed for K19 is almost
identical to that in K18. This indicates that the removal of the
second repeat does not affect the local -structure propensity in
the remaining part of the repeat domain of tau.
FIG. 2. Secondary chemical shifts of tau constructs in solution.
Secondary chemical shifts for C (A) and averaged for C and C (B) in
K18 and C in K19 (C) recorded at 5 °C in 50 mM sodium phosphate
buffer, pH 6.9, protein concentration 1 mM. The average shifts in (B)
were calculated as [3(C)  4(C)]/7. Regions of -structure pro-
pensity are identified by negative values of av(C
C) extending over
several residues and are highlighted by boxes in (B). Repeat boundaries
are indicated by vertical dashed lines. All glycines at position two and
three in the PGGG motifs exhibited identical secondary chemical shifts.
Conformations and Interactions of Tau24980
 at M
ax Planck Inst.Biophysikalische Chem
ie,O
tto Hahn Bibl,Pf.2841,37018 G
oettingen on M









Characterization of K18 and K19 and Its Polyanion Com-
plexes—NMR signals of backbone amides constitute excellent
probes of complex formation, providing maps of the interaction
interfaces and binding constants (24). The binding of the polya-
nions heparin and poly-Glu to K18 and K19 was monitored by
1H-15N HSQC spectra. The size of the chemical shift changes
for increasing polyanion concentrations depends on the binding
strength to the corresponding residues. At high polyanion con-
centrations chemical shift changes of some residues were ac-
companied by a decrease of the intensity of their signals, indi-
cating chemical shift exchange intermediate on the NMR time
scale (Fig. 3).
In the case of heparin the residues exhibiting the largest
displacements in the amide resonances of K18 were Val275-
Leu284 at the beginning of the second repeat (Fig. 4A). In
addition, strong chemical shift changes were observed in the
environment of selected lysine and histidine residues: Leu253-
Lys254, His268-Gln269, Lys298-Val300, His329-Lys331, and His362.
The importance of lysine and histidine residues suggests that
the binding to polyanions is electrostatically driven. Upon ti-
tration of K18 with poly-Glu, a similar pattern of chemical shift
changes was observed (Fig. 4B), indicating that the overall
binding behavior for the two types of polyanions is similar. In
K19, repeat 2 is missing and can therefore not contribute to the
interaction with polyanions. However, the same lysine and
histidine residues as in K18 were strongly affected. In addition,
slightly more pronounced chemical shift changes were observed
for Val306-Lys311, the six residues in the third repeat that are
important for tau aggregation to PHFs (Fig. 4, C and D).
Concomitant with the chemical shift changes and the disap-
pearance of some resonances at high polyanion concentrations
(caused by ligand binding), the overall signal intensity in the
1H-15N HSQC spectra decreased with increasing polyanion
concentration (after correction for dilution effects). The latter
effect is likely due to partial aggregation, because biochemical
analysis indicated that at the end of the polyanion titration
50% of K18 was polymerized, as analyzed by pelleting and
SDS-PAGE. A similar behavior was observed in the K19-poly-
Glu titration.
To investigate the effect of aggregation further, we per-
formed a series of 1H-15N HSQC spectra, in which the ratio of
concentration between heparin and K18 (1:4) was held con-
stant, and the sample was kept for variable times at 50 °C to
induce and accelerate aggregation. After measurement of ini-
tial 1H-15N HSQCs without heparin and with a heparin:K18
ratio of 1:4 at 5 °C, the sample was heated to 50 °C and kept at
this temperature for 2 h. After the 2 h the sample was cooled
down to 5 °C, and an HSQC spectrum was recorded. This
procedure was repeated five times, such that the protein was
kept at 50 °C for 10 h in total. The addition of heparin induced
the chemical shift changes that were reported in Fig. 4. The
peak intensities for most residues were reduced by less than
15% upon addition of heparin with the exception of those res-
idues showing very strong chemical shift changes. After the
first 2 h at 50 °C the intensities of almost all peaks were
reduced to 72% compared with the starting spectrum without
heparin. There was no area in the protein that was affected
particularly strongly, rather an overall loss of signal intensity
was observed. At the same time, the chemical shift changes
that were initially induced by addition of heparin were largely
lost, i.e. the spectrum after 2 h at 50 °C with a heparin:K18
ratio of 1:4 was highly similar to the one of K18 before addition
of heparin (shown in Fig. 3). After 4, 6, 8, and 10 h at 50 °C the
overall signal intensity in 1H-15N HSQC spectra continuously
decreased to 68, 65, 64, and 61% compared with the starting
spectrum without heparin, respectively. No large chemical
shift differences relative to the spectrum after 2 h at 50 °C were
observed. In addition, the average transverse 15N relaxation
time did not change compared with free K18 upon addition of
heparin or after keeping the protein up to 10 h at 50 °C (data
not shown). At the end of the temperature titration biochemical
analysis indicated that 50% of K18 was polymerized. These
data indicate that the observed chemical shift changes were
because of the binding of the polyanion to the protein and not
because of aggregation. When the protein was exposed to high
levels of heparin for prolonged times or to high temperature at
a constant heparin:K18 ratio of 1:4, part of the protein aggre-
gated. As the chemical shift changes, which were induced by
addition of heparin, were largely removed upon aggregation,
heparin may become bound to the aggregates, thereby reducing
the effective concentration of heparin in solution.
The Binding Mode of MTs and Polyanions to Tau Is Simi-
lar—The binding of K18 and K19 to MTs was characterized
using the NMR chemical shift perturbation method (24) in
which two-dimensional 1H-15N HSQC spectra of K18 and K19
were recorded in the presence of increasing amounts of taxol-
stabilized MTs. The influence of temperature was probed by
performing the NMR titrations at 5 and 20 °C. To ascertain the
stability of the taxol-stabilized MTs at these temperatures,
aliquots from the reactions of tau with MTs were characterized
by sedimentation, SDS-PAGE, and electron microscopy (Fig. 5).
After assembly at 37 °C the MTs exhibit the typical morpho-
logical features of protofilaments spaced 5 nm apart. During
the NMR analysis the sample is incubated for more than one h
at 5 °C, but this does not lead to the disintegration of MTs in
the presence of taxol (Fig. 5, A and B). In the presence of tau the
surface features of MTs become somewhat fuzzier but without
a change in subunit arrangement (see Santarella et al., 2004
FIG. 3. NMR titration of K18 with polyanions and MTs. Overlay of the 1H-15N HSQC spectra of 0.20 mM K18 (blue) with 0.15 mM heparin
(red) (A), 0.30 mM K18 (blue) with 1.3 mM poly-Glu (red) (B), and 0.13 mM K18 (blue) with 0.80 mM MTs (red) (C). Spectra were recorded at 5 °C
in 50 mM sodium phosphate buffer, pH 6.9. Some particularly strong shifts are indicated by arrows. In A the signal of Asn279 (N279) was already
attenuated below detection, indicating a chemical shift exchange intermediate on the NMR time scale.
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(39)) (Fig. 5C). For a quantitative analysis the samples were
centrifuged, and the supernatants and pellets were checked by
SDS-PAGE (Fig. 5, D and E). After MT assembly with taxol and
incubation at 20 or 5 °C tubulin is found mostly in the pellet
fraction (Fig. 5D). When increasing amounts of MTs were
added to K18, the binding resulted in increasing amounts of
K18 in the pellet fraction (Fig. 5D). The same was true for K19.
These experiments show that the taxol-stabilized MTs persist
over the time course of the NMR measurement and that bind-
ing parameters of both K19 and K18 are in good agreement
with earlier results (3).
Continuous chemical shift changes of selected residues fol-
lowed by the disappearance of the most strongly shifting reso-
nances, especially at 20 °C, were observed. In addition, the
signal:noise ratio rapidly decreased at high MT concentrations,
indicative of an increasing amount of K18 or K19 bound to
MTs. When bound to MTs, the NMR signals of K18 or K19 are
not observable because of very fast relaxation.
At 5 °C the most strongly shifting resonances in K18 were
found mainly in the environment of lysine and histidine resi-
dues: Leu253-Lys254, His268-Gln269, Lys298-Val300, His329-
Lys331, and His362 (Fig. 6A). This indicates that each repeat
contains a binding site for anchoring K18 to MTs. In agreement
with the repetitive nature of the repeat region, these anchors
are primarily located at equivalent positions in each repeat,
just N-terminal to the PGGG motif. The same lysine and his-
tidines resonances were affected at 20 °C, although to a lesser
extent. At 20 °C the most pronounced chemical shift changes
were observed for residues Lys274-Leu284 at the beginning of
the second repeat (Fig. 6B). Within this region Ile278 and
Asn279, together with Lys281 and Leu282 displayed the strong-
est chemical shift changes, whereas Lys280 was only weakly
affected by the addition of MTs.
In the K18-MT titration, only minor chemical shift changes
were observed for resonances located in the beginning of repeat
3. Addition of heparin to K19, on the other hand, had a pro-
nounced effect on residues Val306-Lys311. In addition, slightly
stronger chemical shift changes were observed for these resi-
dues in the K19-MT titration (Fig. 6B and supplemental Fig.
S2). Further evidence for the involvement of the N-terminal
part of the third repeat into binding to MTs comes from the
decrease of the signal intensity for increasing MT concentra-
tions. The signal intensity for residues Val306-Lys311 decreased
as quickly as that of the interacting part of the second repeat,
i.e. the site that showed the strongest chemical shift changes
upon addition of MTs to K18, and decreased more rapidly than
the intensity for other residues in the K19-MT titration (sup-
plemental Fig. S3). Overall, the pattern of chemical shift
changes induced by addition of MTs was very similar for K18
and K19 (Fig. 6, A and C).
We concluded that repeats R1–R4 of four-repeat tau are
attached to MTs mainly via the positive charges just upstream
of the PGGG motif. The attachment of repeat one is further
stabilized by electrostatic interactions involving the positive
charge of Lys254. In addition, the region Lys274-Leu284 is im-
portant for binding to MTs. An additional MT-binding site is
located in the beginning of the third repeat, which it is partic-
ularly important for binding of three-repat tau to MTs.
DISCUSSION
Tau is an interesting protein from several different perspec-
tives. First, tau is one of the major microtubule-associated
proteins in the brain; it plays a prominent role in the formation
of axons and is therefore important for understanding neuronal
cell biology and brain development. Secondly, tau is a prototype
of the emerging class of “natively unfolded” or “intrinsically
unstructured” proteins whose properties are not accessible by
x-ray crystallography. Thirdly, from a medical perspective tau
represents one of the hallmarks of Alzheimer disease, the most
common form of dementia, where it forms pathological protein
FIG. 4. Binding of polyanions to tau. The mean weighted 1H-15N chemical shifts between the 1H-15N HSQC spectra of free tau and tau in the
presence of polyanions are shown. A, 0.2 mM K18 with 0.15 mM heparin (1:1); B, 0.25 mM K18 with 1.3 mM poly-Glu (1:5); C 0.09 mM K19 with
1.3 mM heparin (1:14); and D 0.12 mM K19 with 1.35 mM poly-Glu (1:11). Resonances that were attenuated below detection by addition of
polyanions are indicated by open bars. Gaps are due to overlap or the presence of prolines. The average molecular weight of heparin and poly-Glu
was 3000 and 10,000, respectively. Repeat boundaries are indicated by vertical dashed lines. * indicate histidine-lysine dyads downstream of PGGG
motifs.
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aggregates that are toxic to the neurons. These reasons
prompted us to apply state of the art, multidimensional NMR
spectroscopy, with the aim of identifying the structural fea-
tures of tau that are responsible for its physiological and path-
ological roles. In the present study we focus on the repeat
domain of tau that forms the core of the MT-binding domain as
well as the core of Alzheimer paired helical filaments (PHFs).
We have used NMR spectroscopy to detect structural motifs
and potential seeds of aggregation in the repeat region of tau
and to characterize its interaction with MTs and certain polya-
nions that are known to promote the aggregation into PHFs.
The major results can be summarized as follows (Fig. 7). 1)
The beginning of each repeat is characterized by a stretch of
8–10 residues with negative secondary chemical shift values.
For the case of R2–R4 this indicates a high propensity of
-structure. These regions coincide with sequence motifs
known to be involved in the abnormal aggregation of tau. The
-forming motifs are sandwiched between motifs that have a
high propensity for turns and therefore interrupt the -confor-
mation (e.g. the PGGG motifs). Additional stretches of -pro-
pensity occur upstream of the PGGG motifs in repeats R2 and
R4. 2) The conformational preferences are the same in different
variants of tau with 3 or 4 repeats (corresponding to fetal or
adult tau). This suggests that the repeats behave like independ-
ent-folding units. 3) MTs and other polyanionic binding part-
ners of tau show similar preferred regions of interaction. They
include the beginning of repeats R2 and R3 (coincident with the
PHF-forming hexapeptide motifs) and spots of high positive
charge upstream of the PGGG motifs. This supports the view
that the abnormal aggregation (caused by polyanionic cofac-
FIG. 5. Analysis of MT stability and interaction with tau by
electron microscopy and SDS-PAGE. A, the morphology of MTs
after assembly at 37 °C exhibit the typical features of MTs with a
width of about 25–28 nm and 6–7 visible protofilaments. After incu-
bation at 4 °C the morphology is not altered (B). In the presence of tau
(C) the surface of the MTs appears fuzzier than in the absence of tau.
Bar  100 nm. The stability of MTs at different concentrations and
the interaction with K18 (130 M) was further analyzed by centrifu-
gation (100,000  g for 1 h at 4 °C) and subsequent SDS-PAGE on
17% SDS gels. D, MTs pelleted after incubation at 20 and 5 °C (lanes
2–7). Samples of the interaction studies were directly centrifuged
after the NMR analysis (lanes 8–11). E, similar analysis of the inter-
action between K19 and MT s. K19 at a fixed concentration (140 M)
was incubated with increasing concentrations of MTs and after cen-
trifugation supernatants, and pellets were applied to a 17% SDS-
PAGE. tub, tubulin.
FIG. 6. Binding of tau to preassembled MTs. Mean weighted
1H-15N chemical shifts between the 1H-15N HSQC spectra of free tau
and tau in the presence of MTs. A, 0.13 mM K18 with 79 M MTs at 5 °C;
B, 0.13 mM K18 with 79 M MTs at 20 °C; and C, 0.14 mM K19 with 35
M MTs at 5 °C. Resonances that were attenuated beyond detection by
addition of MTs are indicated by open bars. Gaps are due to overlap or
the presence of prolines. Repeat boundaries are marked by vertical
dashed lines. * and ° indicate histidine-lysine dyads downstream of
PGGG motifs and serines known to be phosphorylated, respectively.
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tors) is based on the same structural features as the physiolog-
ical interaction with MTs.
Soluble Tau Contains Residual -Structure Providing Seeds
of Aggregation—To allow a high-resolution characterization by
NMR, it was necessary to assign the backbone resonances of all
residues. Previously, the NMR resonances of single residues, at
most dipeptides, were assigned unambiguously covering only
12% of the repeat domain of tau. These isolated assignments
did not provide any indication for residual structure (25). De-
spite the high degree of overlap caused by the absence of a well
defined secondary and three-dimensional structure, we were
able to fully assign the backbone resonances of K18 and K19.
NMR chemical shifts are sensitive probes for the environments
of nuclei. Comparison of the assigned backbone resonances
showed that signals of Val275 and Gln276 at the beginning of R2
in K18 were exactly coincident with the signals of Val306 and
Gln307 at the beginning of R3 in K19. Either the chemical shifts
are dominated by the local sequence composition or any po-
tentially present residual structure is very similar in K18
and K19.
At the beginning of repeats R2, R3, and R4 a significant
propensity for -structure within continuous stretches of 8–10
residues could be identified (16, 24, and 13%, respectively).
These -regions terminate on both ends by motifs with a high
propensity for turns, such as the PGGG motifs or the SN or SK
dyads. The -structure propensity is most pronounced (24%)
for residues Ser305-Asp314 in the beginning of R3. Note that this
is an average value calculated for all residues within this
regions, and it does not necessarily indicate that all residues
populate -structure at the same time. In addition, negative
secondary chemical shifts for residues 295KDNIK299 and 357LD-
NIT361 suggest a weak propensity for -structure in the C-
terminal half of repeats R2 and R4. These findings are in
agreement with other data (x-ray scattering, CD, gel filtration,
secondary structure predictions, etc.) indicating that tau has a
very low content of secondary structure (Schweers et al. (7)).
While this manuscript was in preparation an NMR study of
K19 was published (26). Similar to our results, these authors
observed a tendency to form -structure in the beginning of R3.
No tendency to form a -structure is reported for R4. In addi-
tion, as only K19 was studied, neither the structural properties
of R2 nor any isoform-specific differences between three- and
four-repeat tau could be addressed. Most strikingly, however,
Eliezer et al. (26) concluded that much of K19, comprising
residues 253–267, 315–328, and 346–361, preferentially popu-
lates helical conformations. This conclusion was based mainly
on long stretches of positive C secondary chemical shifts. We
were not able to observe such positive C secondary chemical
shifts (Fig. 2A), despite the fact that our pattern of C second-
ary chemical shifts is very similar to that reported by Eliezer et
al. (26) (supplemental Fig. S1). Our data are in agreement with
earlier results obtained by CD and FTIR spectroscopy, in which
no helical propensities were detected for monomeric K18 or
K19 (13). In addition, we have characterized the interaction of
K18 and K19 with polyanions and microtubules, and the high
degree of similarity between the binding of polyanions and
microtubules suggests that stable microtubules prevent PHF
formation by blocking the tau-polyanion interaction sites,
which are crucial for PHF formation (see below).
The partially populated -structure at the beginning of R2
and R3 is also consistent with the essential role of two hexapep-
tide motifs, 275VQIINK280 and 306VQIVYK311, for the assembly
of tau into PHFs. 306VQIVYK311 represents the minimal
hexapeptide motif for tau-tau interaction and is capable of
inducing tau aggregation. In addition, a 43-residue fragment of
K19, which contains the third repeat of tau and some flanking
residues, acquires a pronounced -structure in conditions
of self-assembly (8). The key role of the hexapeptide
306VQIVYK311 in R3 for PHF aggregation and its pronounced
-structure propensity is also in agreement with data on pep-
tide fragments comprising a single repeat: Trifluoroethanol at
low concentrations only induced an -helical structure in the
hexapeptide in R2 but not in 306VQIVYK311 in R3 (27, 28).
Furthermore, the isolated hexapeptides 275VQIINK280 and
306VQIVYK311 are able to polymerize with formation of -struc-
ture (13, 14).
Several mutations in the tau gene have been linked to fron-
totemporal dementias and parkinsonism (FTDP-17 (29)). Their
mode of action may not be uniform, but some of them appear to
enhance aggregation by increasing the -structure propensity
within the repeat domain. This holds particularly for the mu-
tations K280 and P301L, which are located in or near the
regions with high -structure propensity in the wild-type pro-
tein (13). A higher -structure propensity leads to more mole-
cules that preferentially adopt a -structure thereby increasing
the rate of aggregation. Conversely, proline mutants intro-
duced into these regions disrupt the -propensity and thus
render the molecule largely incapable of PHF formation (8).
The repeat region of four-repeat tau contains two cysteines
whose cross-linking strongly attenuates aggregation by forma-
tion of an inactive monomer (6). These two cysteines are just
C-terminal of the regions of high -propensity. This suggest
that cross-linking of these cysteines brings together the regions
of high -propensity in repeats R2 and R3 forming a partially
populated intramolecular -sheet. Such an intramolecular
-sheet would reduce the tendency to form PHFs, as PHF
assembly requires the formation of intermolecular H-bonds
within these regions. On the other hand, cross-linking of tau
molecules into dimers by intermolecular disulfide bonds can
bring regions of high -propensity close together. This would
favor formation of intermolecular -sheets in agreement with a
strong enhancement of aggregation by dimerization (12).
FIG. 7. Summary of results. The sequence of the four repeats of K18
plus the adjacent four amino acids is shown ordered by the repeat
structure. The residues of special significance are highlighted. Red
amino acids are likely to be involved in turn structures, e.g. the PGGG
motifs at the end of each repeat. Yellow amino acids show a negative
secondary C shift, underlined residues exhibit a negative secondary C
chemical shift. At the beginning of R2, R3, and R4 there are regions of
8–10 residues with negative secondary C chemical shifts and negative
secondary C chemical shifts, indicating a residual -structure. The
middle of R2 and R4 contain a further short stretch with negative
secondary C-shifts. The binding sites for polyanions (heparin, poly-Glu,
and MTs) are marked by red circles above the sequence.
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Regions with -Structure Propensity Coincide with Binding
Sites to Polyanions—PHFs isolated from the brains of patients
with Alzheimer disease are not only composed of tau molecules
but contain other nonprotein components, including heparan, a
glycosaminoglycan, the more extensively sulfated form of
which is heparin. In vitro, heparin and other polyanions, such
as poly-Glu and RNA, greatly improve polymerizability of tau.
This is thought to be because of a neutralization of positive
residues as the enhancement is not restricted to a specific
polyanion (30–32). Our results show that the binding of polya-
nions is concentrated around positively charged patches, in-
cluding the KK motif (280–281) at the beginning of repeat R2,
and the KH (267–268, 298–299) or HHK (329–331) motifs near
the end of R1, R2, and R3. By comparison, single positive
charges in equivalent locations have a much weaker effect on
binding (e.g. Lys311 at the beginning of R3, or His362 near the
end of R4). The patterns of the altered backbone chemical shifts
mapped onto the primary sequence (Fig. 4, A and B) were very
similar for heparin and poly-Glu, suggesting a common mode of
binding dictated largely by electrostatic interactions.
The binding of polyanions to the positively charged amino
acids reduces the net charge and therefore decreases the pro-
pensity for random coil (33). Additionally the binding to the
sites of residual -structure might help to stabilize the -con-
formation and might thereby allow interaction of the -strand
with other tau molecules. Thus, polyanions enhance aggrega-
tion by directly stabilizing the regions which are essential for
aggregation. This is opposite to the interaction of -synuclein
with polyamines, which bind to the C-terminal domain of
-synuclein, cause a release of an autoinhibitory residual struc-
ture, and render the hydrophobic patches of the NAC (Non-A
component of Alzheimer disease amyloid) region accessible,
such that -synuclein is able to adopt -sheet conformations
conductive of aggregation (34).
MTs Prevent PHF Formation by Blocking the Tau-Polyanion
Interaction Sites That Are Crucial for PHF Formation—au is
a microtubule-associated protein that regulates diverse and
essential MT functions, including polymerization and stabili-
zation of MT and modulation of MT dynamics. Mutations in tau
associated with frontotemporal dementia with parkinsonism
linked to chromosome 17 (FDTP-17) weaken the interaction
between tau and MTs and cause a decrease in MT stabilization
(35). Therefore, knowledge of the detailed mechanism by which
tau binds to MTs is highly important. In the study presented
herein we have characterized the reversible binding of tau to
preassembled, taxol-stabilized MTs on the level of individual
tau residues. Because it has been demonstrated previously that
the repeat domain of tau is important for MT binding activity,
we targeted our high-resolution study to this region of the
protein.
The NMR titrations identified residues Lys274-Leu284 as an
important region of tau for binding to MTs. This is in agree-
ment with truncation analyses by Goode et al. (36, 37). A 2.3-
and 3.1-fold reduction of MT binding affinity, which was ob-
served when mutating Lys274 or Lys281 to alanine, correlates
well with the strong chemical shift changes observed for Ile278
and Lys281 upon addition of MTs. In addition, Lys280 showed
only small chemical shift changes, consistent with a smaller
contribution to binding affinity as indicated by site-directed
mutagenesis. Besides these strong electrostatic interactions
involving the N-terminal part of R2, the NMR data show that
the tau-MT interaction is further enhanced by discrete inter-
action clusters of positive charges upstream of the PGGG
motifs.
To investigate isoform-specific differences in MT binding
affinity, we also studied the interaction of K19 with MTs.
Previously, it was shown that the C-terminal sequences down-
stream of the repeat region make a strong but indirect contri-
bution to MT binding affinity in three-repeat tau, whereas in
four-repeat tau they almost have no effect. The K19 construct
does not include these C-terminal sequences. However, the
K19-MT NMR data give insight on a residue basis and can be
used to probe for local changes in the MT interaction. The
highly similar pattern of chemical shift changes in K18 and
K19 upon addition of MTs suggests that the lysine-histidine
binding sites upstream of the PGGG motifs, contribute inde-
pendently to the interaction.
Our study does not directly address the nature of the tau
binding sites on tubulin and MTs. It is commonly accepted that
tau interacts with the C terminus of tubulin that is believed to
be exposed on the surface of MTs (38). Comparison of chemical
shift changes observed for K18 and K19 upon addition of MTs
with those observed upon addition of polyanions indicate a very
similar binding mode. Considering that poly-Glu resembles the
Glu-rich C-terminal sequence of tubulin, the NMR data suggest
that the positively charged clusters described above bind to the
C terminus of tubulin. The similar binding mode of tau to MTs
and polyanions also supports the hypothesis that stable MTs
prevent PHF formation by blocking the tau-polyanion interac-
tion sites, which are crucial for PHF formation.
It is known that phosphorylation at KXGS motifs regulate
affinity of tau to MTs (4). We have shown that the repeat
domain of tau binds to MTs through spots of high positive
charge comprising the beginning of R2 and R3, as well as
histidine-lysine regions upstream of the PGGG motifs. Serine
262, 293, 324, and 356 are separated by only four residues from
these histidine-lysine regions carrying two to three positive
charges at the C-terminal end of each repeat. Thus the effect of
phosphorylation can be achieved, because the introduction of
the negative charge of the phosphate group partially neutral-
izes the positive spots required for MT binding. This intramo-
lecular charge neutralization might be favored by the high
flexibility of the protein backbone of tau, which allows the spots
of positive and negative charges to come close together. Even
more, the high flexibility of tau might actually be required to
allow a detailed control of the tau-MT interaction by phospho-
rylation. In addition, the attraction between the phosphate and
the positively charged lysine-histidine region might force a
turn, reducing the propensity for -structure, which was ob-
served for residues 295KDNIK298 and 357LDNIT361 and might
alter the distances between the distributed weak interaction
sites in a way that they no longer fit to their interaction sites on
the MT surface.
The investigations featured above provide a detailed novel
view of the native state of the repeat region of the microtubule-
associated protein tau and its interaction with polyanions and
MTs. The presence of seeds of aggregation at the beginning of
repeats R2 and R3 (hexapeptide motifs), which coincide with
the observed propensity for -structure and the binding regions
of tau to MTs and polyanions, stresses the importance of these
regions for their normal MT regulating function and for their
involvement in the neurodegenerative process in which tau is
assembled into Alzheimer paired helical filaments. The results
presented in this study will be important when assessing fac-
tors or drugs designed to suppress the aggregation of tau in
neurons, and thus to prevent one of the crucial steps in Alzhei-
mer’s disease.
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